Long-term glioblastoma multiforme survivors: A population-based study

Canadian Journal of Neurological Sciences

Volumn 25, Issue 3, 1998, Pages 197-201

  Scott, J N ^a   Rewcastle, N B ^a   Brasher, P M A ^a   Fulton, D ^b   Hagen, N A ^a   MacKinnon, J A ^a   Sutherland, G ^a   Cairncross, J G ^c   Forsyth, P ^a,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d TOM BAKER CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EID: 0031818983     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100034016     Document Type: Article

References (24)

1. Fine HA. The basis for current treatment recommendations for malignant gliomas. J Neuro-Oncol 1994; 20: 111-120.
2. Forsyth PA, Cairncross JG. Treatment of malignant glioma in adults. Curr Opin Neurol 1995; 8: 414-418.
3. Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. Cancer 1979; 44: 1839-1852.
4. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer 1988; 62: 2152-2165.
5. Balmaceda C, Goldman J, Fetell MR. Long-term survival in malignant astrocytomas re-evaluated: are they really oligodendrogliomas? Neurology 1996; 46(2): A451 (Abstr).
6. Elvidge AR, Barone BM. Long-term postoperative survival in two cases of glioblastoma multiforme. J Neurosurg 1965; 22: 382-386.
7. Müller H, Brock M, Ernst H. Long-term survival and recurrence-free interval in combined surgical, radio- and chemotherapy of malignant brain gliomas. Clin Neurol Neurosurg 1985; 87(3): 167-171.
8. Imperato JP, Paleologos NA, Vick NA. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 1990; 28: 818-822.
9. Ullén H, Mattsson B, Collins VP. Long-term survival after malignant glioma: a clinical and histopathological study on the accuracy of the diagnosis in a population-based cancer registry. Acta Oncol 1990; 29: 875-878.
10. Vertosick FT, Selker RG. Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis. Surg Neurol 1992; 38: 359-363.
11. Chandler KL, Prados MD, Malec M, Wilson CB. Long-term survival in patients with glioblastoma multiforme. Neurosurgery 1993; 32(5): 716-720.
12. Salcman M, Scholtz H, Kaplan RS, Kulik S. Long-term survival in patients with malignant astrocytoma. Neurosurgery 1994; 34(2): 213-220.
13. Morita M, Rosenblum MK, Bilsky MH, Fraser RAR, Rosenfeld MR. Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics. J Neuro-Oncol 1996; 27: 259-266.
14. Olivera C, Bartley M, Ferrall S, Phuphanich S. Long-term malignant glioma survivors over ten years: prognostic factors. Proceedings of ASCO 1997; 16: 407a (Abstr).
15. Forsyth PA, Shaw E, Scheithauer B, Layton D, O'Fallon J. 51 Cases of supratentorial pilocytic astrocytoma: a clinicopathologic, prognostic, and flow-cytometric study. Cancer 1993; 72: 1335-1342.
16. Byar DP, Green SB, Strike TA, et al. Prognostic factors for malignant glioma. In: Walker MD, ed. Oncology of the Nervous System. Boston: Marinus Nijhoff, 1983: 379-395.
17. Jaros E, Perry R, Adam L, et al. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumors. Br J Cancer 1992; 66: 373-385.
18. Dorward NL, Hawkins RA, Whittle IR. Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningioma. Br J Neurosurg 1993; 7: 197-199.
19. Pigott TJ, Robson DK, Palmer J, Ward LM. Expression of epidermal growth factor receptor in human glioblastoma multiforme. Br J Neurosurg 1993; 7: 261-265.
20. Fine HA, Dear KBG, Loeffler JS, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993; 71: 2585-2597.
21. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980; 303: 1323-1329.
22. Archibald YM, Lunn D, Ruttan LA, et al. Cognitive functioning in long-term survivors of high grade glioma. J Neurosurg 1994; 80: 247-253.
23. Salford L, Brun A, Nirfalk S. Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg 1988; 69: 506-509.
24. Cairncross JG, MacDonald DR, Ludwin S, et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994; 12: 2013-2021.